Business & Industry
- Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)
- Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain
- Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology
- Pfizer completes licensing agreement with 3SBio
- AstraZeneca enters strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research
Research & Development
- Microbial allies: Bacteria help fight against cancer
- New AI tool pinpoints genes, drug combos to restore health in diseased cells
- Cancer cells can use backup routes to fuel their growth
- Dietary changes could provide a therapeutic avenue for brain cancer
- How cancer puts other cells to work
- ADHD drugs are being prescribed too quickly to preschoolers
- World's first clinical trial showing lubiprostone aids kidney function
Conferences & Events
- Cohort data from Denmark show real-world evidence of stable protection against HPV-related cervical cancer
- New insights into T and B cells offer hope for autoimmune disease sufferers
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
Regulatory Affairs
- FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
- FDA approves new treatment for hemophilia A or B
- FDA approves nasal spray influenza vaccine for self- or caregiver-administration
- FDA approves first nasal spray for treatment of anaphylaxis
- FDA approves nonsteroidal treatment for Duchenne muscular dystrophy